Patents by Inventor Aren Ewing

Aren Ewing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230112730
    Abstract: Provided are methods and compositions for preparing a library of target nucleic acid sequences that are useful for assessing gene mutations for oncology biomarker profiling of samples. In particular, a target-specific primer panel is provided that allows for selective amplification of oncology biomarker target sequences in a sample. In one aspect, the invention relates to target-specific primers useful for selective amplification of one or more target sequences associated with oncology biomarkers from two or more sample types. In some aspects, amplified target sequences obtained using the disclosed methods, and compositions can be used in various processes including nucleic acid sequencing and used to detect the presence of genetic variants of one or more targeted sequences associated with oncology.
    Type: Application
    Filed: August 15, 2022
    Publication date: April 13, 2023
    Applicant: Life Technologies Corporation
    Inventors: David Chi, Aren Ewing, Na Li, Zunping Luo, Amir Marcovitz
  • Patent number: 11447832
    Abstract: Provided are methods and compositions for preparing a library of target nucleic acid sequences that are useful for assessing gene mutations for oncology biomarker profiling of samples. In particular, a target-specific primer panel is provided that allows for selective amplification of oncology biomarker target sequences in a sample. In one aspect, the invention relates to target-specific primers useful for selective amplification of one or more target sequences associated with oncology biomarkers from two or more sample types. In some aspects, amplified target sequences obtained using the disclosed methods, and compositions can be used in various processes including nucleic acid sequencing and used to detect the presence of genetic variants of one or more targeted sequences associated with oncology.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: September 20, 2022
    Assignee: Life Technologies Corporation
    Inventors: David Chi, Aren Ewing, Na Li, Zunping Luo, Amir Marcovitz
  • Publication number: 20220251669
    Abstract: The present disclosure provides compositions and methods, as well as combinations, kits, and systems that include the compositions and methods, for amplification, detection, characterization, assessment, profiling and/or measurement of nucleic acids in samples, particularly biological samples. Compositions and methods provided herein include combinations of microbial species target-specific nucleic acid primers for selective amplification and/or combinations of primers for amplification of nucleic acids from a large group of taxonomically related microorganisms. In one aspect, amplified nucleic acids obtained using the compositions and methods can be used in various processes including nucleic acid sequencing and used to detect the presence of microbial species and assess microbial populations in a variety of samples.
    Type: Application
    Filed: April 8, 2022
    Publication date: August 11, 2022
    Inventors: Shrutii SARDA, Anna MCGEACHY, Rajesh GOTTIMUKKALA, David MERRILL, Heesun SHIN, Aren EWING, Wing LEE, Birgit DREWS, Fiona HYLAND, Janice AU-YOUNG
  • Publication number: 20210062271
    Abstract: Provided are methods and compositions for preparing a library of target nucleic acid sequences that are useful for assessing gene mutations for oncology biomarker profiling of samples. In particular, a target-specific primer panel is provided that allows for selective amplification of oncology biomarker target sequences in a sample. In one aspect, the invention relates to target-specific primers useful for selective amplification of one or more target sequences associated with oncology biomarkers from two or more sample types. In some aspects, amplified target sequences obtained using the disclosed methods, and compositions can be used in various processes including nucleic acid sequencing and used to detect the presence of genetic variants of one or more targeted sequences associated with oncology.
    Type: Application
    Filed: August 28, 2020
    Publication date: March 4, 2021
    Inventors: David CHI, Aren EWING, Na LI, Zunping LUO, Amir MARCOVITZ
  • Publication number: 20200392470
    Abstract: Disclosed are microalgal cells having an ablated or downregulated fatty acyl-ACP thioesterase (FATA) gene, wherein the cell is modified to express a heterologous lysophosphatidic acid acyltransferase (LPAAT) comprising an amino acid sequence that has at least 80% identity to an acyltransferase encoded by SEQ ID NO: 90, 89, 92, 93 or 95 and wherein the modified microalgal cell produces an oil with an elevated ratio of saturated-unsaturated-saturated triglycerides over trisaturated triglycerides as compared to a corresponding unmodified cell. Also disclosed are microalgal oils comprising at least 60% stearate-oleate-stearate (SOS) triglycerides, less than 5% trisaturates and wherein the fatty acid profile of the oil comprises at least 50% C18:0. Related methods of producing an oil are also disclosed.
    Type: Application
    Filed: August 20, 2020
    Publication date: December 17, 2020
    Inventors: Jeffrey Leo Moseley, Jason Casolari, Xinhua Zhao, Aren Ewing, Aravind Somanchi, Scott Franklin, David Davis
  • Publication number: 20190345463
    Abstract: The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.
    Type: Application
    Filed: April 18, 2019
    Publication date: November 14, 2019
    Inventors: David Davis, George Rudenko, Aravind Somanchi, Jason Casolari, Scott Franklin, Aren Ewing
  • Patent number: 10316299
    Abstract: The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: June 11, 2019
    Assignee: CORBION BIOTECH, INC.
    Inventors: David Davis, George N. Rudenko, Aravind Somanchi, Jason Casolari, Scott Franklin, Aren Ewing
  • Publication number: 20180230442
    Abstract: The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 16, 2018
    Inventors: David Davis, George N. Rudenko, Aravind Somanchi, Jason Casolari, Scott Franklin, Aren Ewing
  • Publication number: 20180142218
    Abstract: Recombinant nucleic acids and vector constructs encoding acyltransferases and variant thioesterases, and the acyltransferases and variant thioesterases encoded by the nucleic acids are provided. The acyltransferases and variant thioesterases are useful in fatty acid synthesis and triacylglycerol production. Host cells that express the recombinant nucleic acids as well as methods of cultivating the host cells, methods of producing oils from the host cells are provided. The recombinant host cells and the oils produced therefrom have altered fatty acid profiles and/or triacylglycerols with altered regiospecificity.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 24, 2018
    Inventors: Jeffrey Leo Moseley, Jason Casolari, Xinhua Zhao, Aren Ewing, Aravind Somanchi, Scott Franklin, David Davis
  • Patent number: 9969990
    Abstract: The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: May 15, 2018
    Assignee: Corbion Biotech, Inc.
    Inventors: David Davis, George Rudenko, Aravind Somanchi, Jason Casolari, Scott Franklin, Aren Ewing
  • Patent number: 9518277
    Abstract: Genetically engineered microbial, e.g., Chlorella protothecoides, cells producing microbial oils are useful as a food additive and a source of renewable fuels and industrial chemicals. Lipid biosynthesis genes for Auxenochlorella protethecoides are disclosed that are useful for increasing lipid production and altering fatty acid and triacylglycerol profiles in recombinant microrganisms including cells of the genus Auxenochlorella or Prototheca.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: December 13, 2016
    Assignee: TerraVia Holdings, Inc.
    Inventors: Scott Franklin, Shane Brubaker, George N. Rudenko, Riyaz Bhat, Matthew Shoa-Azar, Aravind Somanchi, Aren Ewing
  • Publication number: 20160010066
    Abstract: The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.
    Type: Application
    Filed: July 10, 2015
    Publication date: January 14, 2016
    Inventors: David Davis, George Rudenko, Aravind Somanchi, Jason Casolari, Scott Franklin, Aren Ewing
  • Publication number: 20140178950
    Abstract: Genetically engineered microbial, e.g., Chlorella protothecoides, cells producing microbial oils are useful as a food additive and a source of renewable fuels and industrial chemicals. Lipid biosynthesis genes for Auxenochlorella protethecoides are disclosed that are useful for increasing lipid production and altering fatty acid and triacylglycerol profiles in recombinant microrganisms including cells of the genus Auxenochlorella or Prototheca.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 26, 2014
    Applicant: Solazyme, Inc.
    Inventors: Scott Franklin, Shane Brubaker, George N. Rudenko, Riyaz Bhat, Matthew Shoa-Azar, Aravind Somanchi, Aren Ewing